Introduction
============

Protein secretion systems in bacterial pathogens are virulence weapons allowing bacteria to successfully infect the host ([@B1], [@B2]). Secreted proteins are essential for nutrients or iron acquisition, to evade the immune system, to subvert host cell signaling, and to replicate within macrophages: in other words to survive and exploit the hostile environment of the host.

Secretion in Gram-negative bacteria has been catalogued in a series of systems, called type I to type V ([@B3], [@B4]). Each type shows a difference in the components involved and in the molecular mechanisms. Type I, type II, and type V usually deliver proteins onto the bacterial cell surface or into the surrounding environment. In some cases, such as the type II-dependent exotoxin A from *P. aeruginosa* ([@B5]), the protein has the capacity to subsequently self-translocate into eukaryotic cells. The type III secretion system (T3SS) of many bacterial pathogens is responsible for the delivery of effectors into eukaryotic cells. This yields a spectacular host cell response, resulting, for example, in complete reorganization of the cytoskeleton, thus promoting or avoiding bacterial uptake ([@B6]--[@B8]). Another system with similar properties found in many pathogens devoid of T3SS is the type IV secretion system (T4SS) ([@B9]). T3SS and T4SS deliver effectors that share similarities with eukaryotic proteins (such as Ser/Thr kinases) and mimic activities of endogenous cellular proteins. These secretion systems provide the pathogen with a unique functional interface with eukaryotic cells to subvert the host response ([@B10]).

A few years ago, a novel secretion system (type VI or T6SS) was identified in *Vibrio cholerae* ([@B11]) and in *Pseudomonas aeruginosa* ([@B12]). It was revealed that about 15 genes encoding this system are present in the genome of hundreds of bacteria ([@B13]) and that their function is extremely relevant for bacterial pathogenesis and host cell survival. In many cases, these genes are induced *in vivo*.

*P. aeruginosa* is the third most commonly isolated nosocomial pathogen, and is lethal for chronically infected cystic fibrosis patients. The genome of this bacterium contains at least three gene clusters encoding T6SS components ([@B12], [@B14]), which are now named *H1-T6SS* to *H3-T6SS* ([@B15]). Importantly, it was reported that mutants affected in *T6SS* genes are attenuated in a rat lung model of chronic infection ([@B16]). Since then, studies have shown that proteins secreted by the T6SS essentially belong to two families, namely Hcp and VgrG. Hcp is a small protein, which forms hexamers. It was proposed that the function of Hcp is to form nanotubes on the bacterial surface ([@B17]) and that these tubes may allow transport of other T6SS-dependent effector proteins. VgrGs contain two domains, which are related to proteins constituting the bacteriophage tail (namely gp5 and gp27) ([@B18]). It has been proposed that the VgrG proteins form trimeric complexes that could be used as puncturing devices to perforate membranes and allow the passage of proteins or macromolecular complexes. In some cases, VgrGs have a C-terminal extension. Bioinformatic analysis showed that some C-terminal domains display homologies with adhesins, protease or actin cross-linking protein ([@B11]). Few data are available about the role/function of VgrG proteins, and the only detailed reports concern VgrG1 from *V. cholerae* ([@B19]) and *Aeromonas hydrophila* ([@B20]). In *V. cholerae*, VgrG1 has a C-terminal actin cross-linking domain and is translocated into host cells, in particular upon internalization of the bacteria by macrophages. The success of this process is important for survival within macrophages and thus for successful infection. In *V. cholerae*, two other VgrG proteins, VgrG2 and VgrG3, have been identified. VgrG2 does not carry a C-terminal extension, whereas VgrG3 contains a peptidoglycan-binding domain.

Little has been experimentally demonstrated about the function of these VgrG proteins. We showed that in the PAO1 *P. aeruginosa* genome, 10 distinct *vgrG*-like genes could be identified. It is unclear why so many *vgrG* genes are found in the genome of one single bacterium. In this study, we characterized three *P. aeruginosa* VgrGs, namely VgrG1a (PA0091), VgrG1b (PA0095), and VgrG1c (PA2685). The corresponding *vgrG* genes are co-regulated with the *H1-T6SS* cluster, whose expression is controlled by RetS ([@B12]). Here, we clearly establish that all three VgrGs are secreted. However, we show that they have different behavior in terms of secretion and multimerization and suggest that they may fulfill specific functions within the T6SS process.

EXPERIMENTAL PROCEDURES
=======================

### 

#### Bacterial Strains, Plasmids, and Growth Conditions

Bacterial strains and plasmids used in this study are described in [Table 1](#T1){ref-type="table"}. *P. aeruginosa* mutants were constructed as described previously ([@B21]). Briefly, 500-bp DNA fragments contiguous to the 5′ (up) and 3′ (down) ends of the target gene were PCR-amplified by using PAK chromosomal DNA template and two pairs of oligonucleotides (Up5′/Up3′ and Down5′/Down3′) ([Table 2](#T2){ref-type="table"}). The fused up/down fragment was obtained by overlapping PCR, cloned into pCR2.1 (Invitrogen), sequenced (GATC, Konstanz, Germany), and subcloned into pKNG101 suicide vector ([@B22]). We constructed the plasmids pHL9, pHL6, pHL13, pHM60, pHL15, and pKNG-Δ*clpV3*, respectively, allowing the deletion of *vgrG1a/PA0091*, *vgrG1b/PA0095*, *vgrG1c/PA2685*, *clpV1/PA0090*, *hcp1/PA0085*, and a partial deletion of *clpV3/PA2371* (region corresponding to the Asn^218^--Ala^632^ domain of ClpV3), respectively. The plasmids were maintained in the *Escherichia coli* CC118λpir strain and conjugated in *P. aeruginosa* strains. The structure of the mutants in which the double recombination events occurred, resulting in the non-polar deletion of the gene of interest, were verified by PCR with external primers. We also engineered strains with plasmid insertion interrupting the *clpV2* or *clpV3* gene. A pair of primers (either 5′-ATCCTGGCCCTGCTACGC-3′ and 5′- CGTCGATGAACAGGATGGTC-3′ or 5′-TCATTACGTAGAGATCGAGCACCT and 5′-CTGCGCCGGCGGCAGAACGCCGACGCC-3′) was used to PCR amplify a 0.5-kb internal fragment of *clpV2 and* a 0.56-kb internal fragment of *clpV3*, respectively. The respective fragments were cloned into pCR2.1, and recombinant plasmids were verified by sequencing. The resulting plasmids, pCR2.1*clpV2*::*bla* and pCR2.1*clpV3*::*bla*, were introduced into *P. aeruginosa* PAKΔ*retS* by electroporation, and carbenicillin-resistant clones were isolated. The position of the insertion, which resulted either in the disruption of *clpV2* at codon 55 or of *clpV3* at codon 218, was verified by PCR. We also engineered a triple mutant, resulting from deletion in *clpV1* and *clpV3* genes, combined with an insertion in the *clpV2* gene ([Table 1](#T1){ref-type="table"}).

###### 

**Strains and plasmids used in this work**

  Strain or plasmid                                  Relevant characteristics[*^a^*](#TF1-1){ref-type="table-fn"}                                                                          Source/Reference
  -------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------- -----------------------
  **Strain**                                                                                                                                                                               
      *E. coli*                                                                                                                                                                            
          Bl21 DE3                                   *E. coli B dcm ompT hsdS*(r~B~^−^m~B~^−^) *gal* λDE3                                                                                  Laboratory collection
          TG1                                        *F*′: *lacI^q^ Tn10 mcrA* Δ(*mrr-hsdRMS-mcrBC*) *supE*Δ(*lac-proAB*) thi hsdRΔ*5* (*F*′*: tra*Δ*36proA*^+^*B*^+^*Z*Δ*M15*)            Laboratory collection
          CC118(λpir)                                Host strain for pKNG101 replication; Δ(*ara-leu*) *araD* Δ*lacX74 galE galK-phoA20 thi-1 rpsE rpoB argE* (Am) *recA1 Rf^r^*(λ*pir*)   Laboratory collection
      *P. aeruginosa*                                                                                                                                                                      
          PAK                                        Wild-type prototroph                                                                                                                  Laboratory collection
          PAKΔ*retS*                                 *retS* deletion mutant                                                                                                                Ref. [@B27]
          PAKΔ*retS*Δ*vgrG1a*                        *vgrG1a* deletion mutant                                                                                                              This work
          PAKΔ*retS*Δ*vgrG1b*                        *vgrG1b* deletion mutant                                                                                                              This work
          PAKΔ*retS*Δ*vgrG1c*                        *vgrG1c* deletion mutant                                                                                                              This work
          PAKΔ*retS*Δ*vgrG1a*Δ*vgrG1b*               *vgrG1a/vgrG1b* double mutant                                                                                                         This work
          PAKΔ*retS*Δ*vgrG1a*Δ*vgrG1c*               *vgrG1a/vgrG1c* double mutant                                                                                                         This work
          PAKΔ*retS*Δ*vgrG1b*Δ*vgrG1c*               *vgrG1b/vgrG1c* double mutant                                                                                                         This work
          PAKΔ*retS*Δ*vgrG1a*Δ*vgrG1b*Δ*vgrG1c*      *vgrG1a/vgrG1b/vgrG1c* triple mutant                                                                                                  This work
          PAKΔ*retS*Δ*clpV1*                         *clpV1* deletion mutant                                                                                                               This work
          PAKΔ*retS*Δ*hcp1*                          *hcp1* deletion mutant                                                                                                                This work
          PAKΔ*retS clpV2*::*bla*                    *clpV2* insertion mutant, Ap^R^                                                                                                       This work
          PAKΔ*retSclpV3*::*bla*                     *clpV3* insertion mutant, Ap^R^                                                                                                       This work
          PAKΔ*retS*Δ*clpV1 clpV2*::*bla* Δ*clpV3*   *clpV1/clpV2/clpV3* triple mutant, Ap^R^                                                                                              This work
                                                                                                                                                                                           
  **Plasmids**                                                                                                                                                                             
      pRK2013                                        Tra^+^Mob^+^, Km^R^                                                                                                                   Laboratory collection
      pETDEST-42                                     Gateway expression vector *tac* promoter, Ap^R^                                                                                       Invitrogen
      pCR2.1                                         TA cloning vector, Ap^R^, Km^R^                                                                                                       Invitrogen
      pHM10                                          pETDEST-42 containing *vgrG1a-V5His6*                                                                                                 This work
      pHM11                                          pETDEST-42 containing *vgrG1b-V5His6*                                                                                                 This work
      pCR2.1*clpV2*::*bla*                           pCR2.1-containing 50--550 nucleotides of *clpV2*                                                                                      This work
      pCR2.1*clpV3*::*bla*                           pCR2.1-containing 589--1151 nucleotides of *clpV3*                                                                                    This work
      pKNG101                                        Suicide vector, *sacB*, Str^R^                                                                                                        This work
      pHM60                                          pKNG101-Δ*clpV1* mutator                                                                                                              This work
      pHL9                                           pKNG101-Δ*vgrG1a* mutator                                                                                                             This work
      pHL6                                           pKNG101-Δ*vgrG1b* mutator                                                                                                             This work
      pHL13                                          pKNG101-Δ*vgrG1c* mutator                                                                                                             This work
      pHL15                                          pKNG101-Δ*hcp1* mutator                                                                                                               This work
      pKNG-Δ*clpV3*                                  pKNG101-Δ*clpV3* mutator                                                                                                              This work
      pMMB67HE                                       Broad-host-range vector, IncQ p*tac lacZ*α Ap^R^                                                                                      Laboratory collection
      pHM14                                          pMMB67HE containing *vgrG1b-V5His6*                                                                                                   This work
      pBBR1MCS-4                                     Broad host range, Ap^R^                                                                                                               Laboratory collection
      pBBR*ladS*                                     pBBR1MCS-4 containing *ladS*                                                                                                          Ref. [@B23]

*^a^* Ap^R^, ampicillin-resistant; Str^R^, streptomycin-resistant; Km^R^, kanamycin-resistant.

###### 

**Oligonucleotides used in this study**

  Deleted gene/oligonucleotide   Oligonucleotide sequence[*^a^*](#TF2-1){ref-type="table-fn"}
  ------------------------------ --------------------------------------------------------------
  ***clpV1***                    
      Up5′                       `GGAAGCTTTACTACTACACCGGCCAC`
      Up3′                       `CGCGGATCCATACTCACTCATGTTCCT`
      Down5′                     `CGCGGATCCTTCGCCGAGGCCGAGTGA`
      Down3′                     `AAAGAATTCCCGGCTGATGAAGCTGAA`
                                 
  ***clpV2***                    
      5′                         `ATCCTGGCCCTGCTACGC`
      3′                         `CGTCGATGAACAGGATGGTC`
                                 
  ***clpV3***                    
      Up5′                       `TCATTACGTAGAGATCGAGCACCT`
      Up3′                       `CTGCGCCGGCGGCAGAACGCCGACGCC`
      Down5′                     `CGGCAGAACGCCGACGCCCTCTACGGC`
      Down3′                     `CTTGTAGCGTTCCCGCAGTTTTTC`
                                 
  ***vgrG1A***                   
      Up5′                       `AACACCCTGATCCTGCTCAC`
      Up3′                       `TCAGCCCTTCGCTTGCATCAATCC`
      Down5′                     `ATGCAAGCGAAGGGCTGAGGCGG`
      Down3′                     `ACCCAAGGTCCTCAACTCCT`
                                 
  ***vgrG1B***                   
      Up5′                       `AATACCTGGCGCAGCATC`
      Up3′                       `TCAGTTCTGAAGTGCCATGAAATCAT`
      Down5′                     `ATGGCACTTCAGAACTGAAGCGGC`
      Down3′                     `GTCGAGCCCCTGGTTGTAG`
                                 
  ***vgrG1C***                   
      Up5′                       `GAACGGCTTCGGCAGGTAGTC`
      Up3′                       `GATATCGACATTCAGTGCCGTCGCGAAAGG`
      Down5′                     `CCTTTCGCGACGGCACTGAATGTCGATATC`
      Down3′                     `AGCCCTCCTGCGTCTGCAGTT`
                                 
  ***hcp1***                     
      Up5′                       `TCGTGCACAAGAAGAACACC`
      Up3′                       `TCAGGCCTGAACAGCCATCTTTCC`
      Down5′                     `ATGGCTGTTCAGGCCTGATGAGC`
      Down3′                     `AGTCGATGGCGGTGGAGTAG`

*^a^* Oligonucleotides are presented in the orientation 5′--3′.

The *vgrG1b* gene, encoding a V5/His-tagged version of VgrG1b (see below), was recloned from pHM11 into the broad host range plasmid pMMB67HE, yielding pHM14. This plasmid as well as the previously described pBBR*ladS* encoding the *ladS* gene ([@B23]) were conjugated by triparental mating using pRK2013 into appropriate *P. aeruginosa* strains.

#### Production of Antibodies Directed against VgrG1a and VgrG1b

Briefly, *vgrG1a* and *vgrG1b* genes from the *P. aeruginosa* gene collection ([@B24]) were transferred by LR recombination (Invitrogen) from the pDONR shuttle vector to the pETDEST-42 expression vector. The plasmids pHM10 and pHM11, allowing production of VgrG1a-V5His6 and VgrG1b-V5His6, respectively, were transformed into *E. coli* BL21 (DE3). The resulting strains were cultured in LB medium at 37 °C under agitation in the presence of 1 m[m]{.smallcaps} isopropyl 1-thio-β-[d]{.smallcaps}-galactopyranoside for 6 h. Inclusion bodies containing the recombinant proteins were isolated from bacterial pellets by sonication on ice in lysis buffer (10 m[m]{.smallcaps} Tris-HCl, pH 8, 1 m[m]{.smallcaps} PMSF). Inclusion bodies were collected by centrifugation at 3000 × *g* for 10 min, washed with lysis buffer twice, and dissolved in 8 [m]{.smallcaps} urea, pH 8, for 1 h at room temperature. Samples were spun for 1 h at 70,000 × *g* at 4 °C, and supernatants were applied to Ni^2+^-NTA columns for purification by imidazole gradients. Eluted proteins were dialyzed against 10 m[m]{.smallcaps} Tris, pH 8, and injected into rabbits for production of antibodies (Eurogentec).

Hcp1 and Tse3 antibodies were raised in rabbits by injecting purified peptides (Eurogentec). The peptides used were VKGESKDKTHAEEID and GPVKYGWNIRQNVQA for Hcp1 or AYAGNPRNWPRDNVRA and EQRDQTRDEDAKDYQ for Tse3.

#### Preparation of Supernatant from P. aeruginosa Culture

*P. aeruginosa* strains were grown overnight in TSB and subcultured to an *A*~600~ of 0.1 until early stationary phase at 37 °C under agitation. Cells were separated from culture supernatants by centrifugation at 4000 × *g* at 4 °C. Cells were resuspended in 1× Laemmli buffer ([@B25]). Proteins from the culture supernatant were precipitated with 10% TCA. Protein pellets were washed in 90% acetone, air-dried, and resuspended in 1× Laemmli buffer for analysis by SDS-PAGE. Samples were boiled at 95 °C for 10 min before SDS-PAGE unless indicated otherwise.

#### SDS-PAGE and Immunoblotting

For SDS-PAGE analysis, cell extracts or 10× concentrated culture supernatants were loaded onto polyacrylamide gels containing SDS followed by transfer to nitrocellulose membrane at 0.03 Amp/cm^2^. Following transfer, membranes were blocked overnight in blocking buffer (5% milk powder, 0.1% Tween 20 in Tris-buffered saline, pH 8.0). Polyclonal antibodies against VgrG1a, VgrG1b, or Hcp1 were used at a dilution of 1:1000, or anti-Tse3 antibodies were used at 1:250. Monoclonal anti-V5 antibody (Invitrogen) was used at a dilution of 1:5000. Monoclonal antibodies against the β subunit of RNA polymerase (Neoclone) and β-lactamase (QED Bioscience) were used at a dilution of 1:1000. Secondary antibodies conjugated to horseradish peroxidase were used at a dilution of 1:5000. Western blots were developed using SuperSignal West Pico Chemiluminescent Substrate (Pierce) and the LAS3000 Fuji Imager. Intensity of the VgrG1a band observed in Western blots was quantified using the freeware program ImageJ (available on the National Institutes of Health Web site).

#### Bioinformatic Analyses

*P. aeruginosa* protein sequences were retrieved from the *Pseudomonas* Genome Database. VgrG proteins encoded on the genome of *P. aeruginosa* were identified through an NCBI BLAST search using the sequence of VgrG1a. The phylogenetic tree of *P. aeruginosa* VgrG proteins was created using the freeware program Phylogeny (available on the World Wide Web). Secondary structure prediction was carried out using the PSIPRED Protein Structure Prediction Server.

The amino acid sequence of VgrG1a was used to perform a structural-based homology prediction using Phyre (available on the World Wide Web) ([@B26]). Two known crystal structures were found to present structural homology to VgrG1a. These structures correspond to Protein Data Bank accession codes [2P5Z](2P5Z) and [1K28](1K28). The precision of the structural prediction is estimated by Phyre to be 100%. This estimated precision takes into account several factors, such as conservation of amino acid sequence, physicochemical properties of aligned residues, and conservation of secondary structural elements.

RESULTS
=======

### 

#### Characterization of the VgrG1a Protein

In order to study VgrG secretion in *P. aeruginosa*, we developed antibodies directed against VgrG1a. VgrG1a is coded by the *PA0091* gene on the *P. aeruginosa* genome and was previously named VgrG1 ([@B15]). This gene is located within the *H1-T6SS* cluster (previously *HSI-I*). *H1-T6SS* genes have been shown to be up-regulated in the absence of the sensor kinase RetS ([@B27]--[@B29]). Here we demonstrate that overproduction of LadS ([@B23]), a sensor antagonistic to RetS, induces expression of *H1-T6SS* genes and results in an active machinery as shown by Hcp1 secretion ([supplemental Fig. S1](http://www.jbc.org/cgi/content/full/M110.193045/DC1)). However, further experiments were carried out in a *retS* mutant background ([@B12], [@B27]). Analysis of whole cell extracts of PAK and PAKΔ*retS* by immunoblotting using antibodies directed against VgrG1a revealed three bands that were specifically detected in PAKΔ*retS* when compared with PAK ([Fig. 1](#F1){ref-type="fig"}*A*). These bands correspond to a molecular mass of 93, 82, and 72 kDa. In order to analyze whether all of the bands were VgrG1a-related, we engineered a deletion mutant of the *vgrG1a* gene in the PAKΔ*retS* background ([Table 1](#T1){ref-type="table"}). Immunoblot analysis of cell extracts of PAKΔ*retS*Δ*vgrG1a* demonstrated that only the lowest of the three bands (72 kDa) was absent and hence corresponded to VgrG1a ([Fig. 1](#F1){ref-type="fig"}*B*). This suggested that the two other bands are proteins recognized by VgrG1a antibodies.

![**Identification of VgrG1a, VgrG1b, and VgrG1c proteins.** *A*, whole cell extracts of PAK and the isogenic mutant PAKΔ*retS* were analyzed by immunoblotting. VgrG proteins were detected using antibodies directed against VgrG1a. Molecular mass standards (kDa) are indicated on the *left. B*, same as in *A*, but extracts from different *vgrG* mutants (indicated above) have been analyzed. All strains are PAKΔ*retS* derivatives. The positions of VgrG1a (*G1a*), VgrG1b (*G1b*), and VgrG1c (*G1c*) are indicated on the *right*.](zbc0201158450001){#F1}

#### Characterization of Additional VgrG1 Proteins

Putative protein candidates for cross-reactivity are other VgrG proteins with high similarity at the amino acid sequence level. We used the deduced amino acid sequence of the *vgrG1a* gene to perform a BLAST search against the genome sequence of PAO1, identifying 10 genes, scattered all over the chromosome, encoding putative VgrG proteins ([Fig. 2](#F2){ref-type="fig"}*A*). The *PA0095* gene is located within the *H1-T6SS* cluster and was shown to be up-regulated in a PAKΔ*retS* genetic background ([@B27]). We called it *PA0095 vgrG1b* because it is located in the vicinity of the *vgrG1a* gene (*PA0091*). Furthermore, we used the amino acid sequence of all *P. aeruginosa* VgrGs to establish a phylogenetic tree ([Fig. 2](#F2){ref-type="fig"}*B*) ([@B30]). Interestingly, VgrG1a and VgrG1b fell within the same branch of the tree, indicating that they are closely related (71% similarity, 64% identity). Furthermore, PA2685 is also found within the same branch and was thus called VgrG1c, although it was previously named VgrG4 ([@B15]) (73% similarity, 66% identity with VgrG1a) ([Fig. 2](#F2){ref-type="fig"}*B*). The sequence alignment presented in [Fig. 3](#F3){ref-type="fig"} clearly shows the similarity between VgrG1a, VgrG1b, and VgrG1c. In addition, secondary structure prediction showed the succession of β-strands within the C-terminal region, which is characteristic of the gp5 structure of the T4 bacteriophage ([@B18]) ([Fig. 3](#F3){ref-type="fig"}). It should be noted that, despite the various lengths of the C termini, these consist only of β-strand repeats and are thus exclusively gp5-like. VgrG1a, VgrG1b, and VgrG1c contain 20, 33, and 26 β-strands, respectively. A model of the predicted three-dimensional structure of VgrG1a is shown in [supplemental Fig. S2](http://www.jbc.org/cgi/content/full/M110.193045/DC1). In order to assess whether the two additional bands detected by VgrG1a antibodies ([Fig. 1](#F1){ref-type="fig"}*B*) correspond to VgrG1b and VgrG1c, *vgrG1b* and *vgrG1c* deletion mutants were constructed in PAKΔ*retS*. Furthermore, multiple *vgrG* deletions within a single strain were also obtained (see "Experimental Procedures" and [Table 1](#T1){ref-type="table"}). Remarkably, we observed that the 82 kDa band corresponds to VgrG1c because it is absent in *vgrG1c* and *vgrG1ac* mutants, and the 93 kDa-band corresponds to VgrG1b because it is absent in *vgrG1b* and *vgrG1ab* mutants ([Fig. 1](#F1){ref-type="fig"}*B*).

![***P. aeruginosa* VgrG proteins.** *A*, the chromosome design was generated using Geneious version 5.1 (available on the World Wide Web). Distribution of the *vgrG* and *hcp* genes on the PAO1 genome is shown. Relative positions of *vgrG* genes (named G1a to G6) are indicated with *green flags*, and *hcp* genes are shown with *gray flags. Flags* representing genes of interest in the study have been *boxed* (*vgrG1a*, *vgrG1b*, and *vgrG1c*). In all cases, the corresponding PA number is indicated ([@B39]). The positions of the type VI secretion (T6SS) gene clusters are *flagged* in *dark gray*. Three T6SS clusters are identified, *H1-T6SS*, *H2-T6SS*, and *H3-T6SS* ([@B15]). *B*, phylogenetic analyses of *P. aeruginosa* (PAO1) VgrG proteins using Phylogeny.fr. Graphical representation of the inferred tree is shown. VgrG1a, VgrG1b, and VgrG1c are clustered at the *bottom* of the tree.](zbc0201158450002){#F2}

![**Sequence alignment of VgrG1a, VgrG1b, and VgrG1c.** Residues predicted to fold into α-helices and β-strands are *shaded* in *black* and *gray*, respectively. *Two levels* of *gray* are used; *light* and *dark gray* indicate β-strands predicted to have structural homology to the N-terminal domain of C3393 (gp27-like domain of VgrG in *E. coli*) and the C-terminal domain of gp5, respectively (see [supplemental Fig. S2](http://www.jbc.org/cgi/content/full/M110.193045/DC1) for details). The shown secondary structure prediction corresponds to the consensus between psipred, jnet, and sspro programs. The sequence consensus is shown *below* aligned sequences, where *letters* in *uppercase* and *lowercase* correspond to residue conservation in all three or in two of three sequences, respectively. The *underlined residues* correspond to the predicted coil region where the gp5 domain starts.](zbc0201158450003){#F3}

#### ClpV1-dependent Secretion of VgrGs

We analyzed whether the VgrG1a/b/c proteins were secreted into the extracellular medium. VgrG1a and VgrG1c were detected in significant amounts in the culture supernatant, although quite a large amount accumulated within the cells ([Fig. 4](#F4){ref-type="fig"}). On the contrary, VgrG1b was not detectable in culture supernatants using VgrG1a antibodies. However, when antibodies directed against VgrG1b were used, secretion of VgrG1b was readily observed ([Fig. 5](#F5){ref-type="fig"}, *lane 1*). In all cases, secretion was not the result of cell lysis because the cytoplasmic protein RNA polymerase (RNAP)[^4^](#FN4){ref-type="fn"} was detected in the cell fraction but not in culture supernatants ([Figs. 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}).

![**ClpV1-dependent secretion of VgrG proteins.** Whole cell extracts (*Cells*) and proteins from culture supernatants (*SN*) of PAKΔ*retS* and the *clpV1* mutant derivative (indicated *above* each *lane*) were analyzed by immunoblotting. Cytosolic RNAP was detected using an antibody directed against its β subunit. VgrG proteins were detected using antibodies directed against VgrG1a. All strains are PAKΔ*retS* derivatives. The positions of VgrG1a (*G1a*), VgrG1b (*G1b*), and VgrG1c (*G1c*) are indicated on the *right*. Molecular mass standards (kDa) are indicated on the *left*.](zbc0201158450004){#F4}

![**T6SS-independent secretion of VgrG1b.** Whole cell extracts (*Cells*) and proteins from culture supernatants (*SN*) of PAKΔ*retS*, *vgrG1b*, and *clpV* mutant derivatives (*clpV1*, *clpV2*, *clpV3*, or triple *clpV1V2V3*; indicated *above* each *lane*) were analyzed by immunoblotting. VgrG1b proteins were detected using antibodies directed against VgrG1b. Hcp1 was detected with anti-Hcp1 antibodies. Cytoplasmic RNAP was detected using an antibody directed against its β subunit. The positions of VgrG1b (*G1b*), Hcp1, and RNAP are indicated on the *right*. The band marked with an *asterisk* represents an uncharacterized protein recognized by antibodies directed against VgrG1b. Molecular mass standards (kDa) are indicated on the *left*.](zbc0201158450005){#F5}

We then tested whether the secretion of the VgrG proteins was H1-T6SS-dependent. A deletion mutant in *clpV1*, a gene encoding a key component of the H1-T6SS, was constructed ([Table 1](#T1){ref-type="table"}). In the *clpV1* mutant, secretion of both VgrG1a and VgrG1c was not detectable ([Fig. 4](#F4){ref-type="fig"}), which confirmed previous data obtained by Hood *et al.* ([@B15]). Interestingly, the level of VgrG1a in the cells of a *clpV1* mutant seemed reduced ([Fig. 4](#F4){ref-type="fig"}). A reduction of 54 ± 14% in the intensity of the VgrG1a band (as determined with ImageJ in 10 independent experiments) in *PAK*Δ*retS*Δ*clpV1* mutant as compared with PAKΔ*retS* confirmed this initial observation. VgrG1c or VgrG1b levels remained unaffected in the *PAK*Δ*retS*Δ*clpV1* mutant ([Figs. 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}). This could suggest that VgrG1a is unstable in the absence of ClpV1. Alternatively, the *clpV1* mutation may have a polar effect on the expression of *vgrG1a.* Surprisingly, using VgrG1b-specific antibodies, we observed that VgrG1b secretion was ClpV1-independent and thus H1-T6SS-independent ([Fig. 5](#F5){ref-type="fig"}). We engineered mutants in *clpV* genes found in the other two *T6SS* clusters (*clpV2* and *clpV3*) and observed that VgrG1b secretion was still effective in these mutants ([Fig. 5](#F5){ref-type="fig"}). Furthermore, using a strain in which mutations in *clpV1*, *clpV2*, and *clpV3* were combined, rendering all three *P. aeruginosa* T6SS inactive, VgrG1b secretion was still not affected ([Fig. 5](#F5){ref-type="fig"}). Thus, VgrG1b secretion is independent of the three known *T6SS* clusters.

#### Relationship between VgrG1b and H1-T6SS

Under "ClpV1-dependent Secretion of VgrGs," we showed that VgrG1b was recovered in the supernatant of a *retS* mutant and that its secretion was unaffected by deletion of *clpV1*, *clpV2*, or *clpV3* ([Fig. 5](#F5){ref-type="fig"}), suggesting that VgrG1b was secreted independently of any *P. aeruginosa* T6SS. To support the hypothesis of T6SS-independent VgrG1b secretion, secretion of VgrG1b was analyzed in PAK, a strain in which the *H1*- to *H3-T6SS* genes are not induced. The recombinant plasmid pHM14, encoding V5/His-tagged VgrG1b, was introduced in both PAK and the isogenic *retS* mutant. Recombinant VgrG1b was detectable in both cells and culture supernatant using anti-V5 antibody in both PAK and PAKΔ*retS* ([Fig. 6](#F6){ref-type="fig"}). However, it is interesting to note that no difference was observed between PAK (no active T6SSs) and the *retS* mutant (active H1-T6SS), suggesting that the weak secretion of VgrG1b is T6SS-independent. Monitoring the localization of periplasmic β-lactamase, encoded by the pMMB67HE plasmid, showed that there is no leakage of this enzyme into the supernatant ([Fig. 6](#F6){ref-type="fig"}). Thus, detectable VgrG1b secretion in the culture supernatant was not a result of cell lysis or periplasmic leakage but due to a specific secretion process.

![**Overproduction and secretion of VgrG1b in PAK.** Secretion of VgrG1b was monitored in PAK and PAK Δ*retS* after production of V5/His-tagged VgrG1b from the plasmid pHM14. Cell fraction (*Cells*) and supernatant fraction (*SN*) were analyzed by immunoblotting using anti-V5 (*V5*) (*top*), anti-β-lactamase (*Bla*) (*middle*), and anti-Hcp1 antibodies (*Hcp1*) (*bottom*). Molecular mass standards (kDa) are indicated on the *left*.](zbc0201158450006){#F6}

As for Hcp1 and VgrG1a/c, VgrG1b production was clearly induced in a *retS* mutant compared with the PAK strain ([Fig. 7](#F7){ref-type="fig"}, *top*). To analyze if VgrG1b was required for a functional H1-T6SS, secretion of Hcp1 and VgrG1a/c was analyzed in a *vgrG1b* mutant (PAKΔ*retS*Δ*vgrG1b*). We confirmed that *P. aeruginosa* Hcp1 is secreted into the culture supernatant of PAKΔ*retS* ([Fig. 7](#F7){ref-type="fig"}, *lane 2*) and that it is VgrG1b-independent because it was also observed in the culture supernatant of the PAKΔ*retS*Δ*vgrG1b* mutant ([Fig. 7](#F7){ref-type="fig"}, *lane 3*). Furthermore, neither VgrG1a nor VgrG1c secretion was affected by deletion of *vgrG1b* ([Fig. 7](#F7){ref-type="fig"}, *second panel*). Overall, these results indicate that although *vgrG1b* is co-expressed with *H1-T6SS* genes, VgrG1b neither impacts secretion of components of the H1-T6SS nor requires H1-T6SS components for its own secretion.

![**Deletion of *vgrG1b* does not affect Hcp1 and VgrG1a/c secretion.** The H1-T6SS is not expressed in PAK but is induced in PAKΔ*retS.* Cell and supernatant fractions of PAK, PAKΔ*retS* (*retS*), and PAKΔ*retS*Δ*vgrG1b* (*retS vgrG1b*) were analyzed by immunoblotting using antibodies directed against VgrG1b (*top panel*), VgrG1a (*second panel*), Hcp1 (*third panel*), and the β subunit of RNAP (*bottom panel*). Molecular mass standards (kDa) are indicated on the *left*, and protein bands are identified on the *right*.](zbc0201158450007){#F7}

#### Secretion Dependence between Hcp1 and VgrG1a-c

We further studied whether *P. aeruginosa* Hcp1 secretion was dependent on VgrG1a or VgrG1c. We observed that Hcp1 was still secreted by a single *vgrG1a or vgrG1c* mutant, but the secretion efficiency was reduced ([Fig. 8](#F8){ref-type="fig"}*A*). However, when the *vgrG1a* mutation was combined with the *vgrG1c* mutation, Hcp1 secretion was abolished ([Fig. 8](#F8){ref-type="fig"}*A*). In conclusion, VgrG1a and VgrG1c are essential for efficient Hcp1 secretion but can function independently. Indeed, we observed that one VgrG compensates for the absence of the other. This observation differs from the situation observed in *V. cholerae* ([@B31]). Notably, Hcp secretion is totally abolished in a *V. cholerae vgrG2* mutant, whereas residual secretion is observed in a *vgrG1* mutant. Interestingly, VgrG3 appears not to be required for *V. cholerae* Hcp secretion.

![**VgrG-dependent secretion of Hcp1 and VgrGs.** Whole cell extracts (*Cells*) and proteins from culture supernatants (*SN*) of PAKΔ*retS* and PAKΔ*retS* mutant derivatives *vgrG1a*, *vgrG1c*, double *vgrG1a/vgrG1c* (*vgrG1ac*), and *hcp1* (indicated *above* each *lane*) were analyzed by immunoblotting. *A*, Hcp1 protein was detected using antibodies directed against Hcp1. *B*, VgrG proteins were detected using antibodies directed against VgrG1a. The positions of VgrG1a (*G1a*), VgrG1b (*G1b*), VgrG1c (*G1c*), and Hcp1 are indicated on the *right*.](zbc0201158450008){#F8}

Furthermore, we demonstrated that secretion of VgrG1a is not dependent on VgrG1c and *vice versa* ([Fig. 8](#F8){ref-type="fig"}*B*). This is similar to *V. cholerae*, in which VgrG1 secretion is not dependent on VgrG2 and vice versa ([@B31]). Finally, VgrG1a and VgrG1c secretion is reduced but not abolished in an *hcp1* mutant ([Fig. 8](#F8){ref-type="fig"}*B*).

#### VgrGs Form Multimeric Complexes

VgrG proteins share similarity with the gp5 and gp27 bacteriophage components, which form a stable complex constituting the bacteriophage tail spike ([@B31]). We used the sequence of the VgrG1a protein from *P. aeruginosa* PAO1 to perform a structure-based homology prediction using several bioinformatics tools and databases ([@B26], [@B32]). The results clearly indicated that VgrG1a (643 amino acids) is composed of distinct domains and that a trimer is the biologically relevant oligomer ([supplemental Fig. S2](http://www.jbc.org/cgi/content/full/M110.193045/DC1)). The predicted VgrG1a structure is very similar to the T4 phage (gp5-gp27)~3~ structure reported previously (Protein Data Bank entry [1K28](1K28)).

To analyze the relevance of this model, we investigated whether VgrG1a could form multimers *in vivo*. Supernatants from *P. aeruginosa* cultures were collected, and the protein content was analyzed by immunoblotting using anti-VgrG1a ([Fig. 9](#F9){ref-type="fig"}*A*). A band with a high molecular weight, suggesting multimer formation, was detected as well as monomeric forms of VgrG1a and VgrG1c ([Fig. 9](#F9){ref-type="fig"}*A*, *lane 2*). The complex seems to contain VgrG1a and/or VgrG1c because it was not detectable in a double *vgrG1a/vgrG1c* mutant ([Fig. 9](#F9){ref-type="fig"}*A*, *lane 3*). This is in agreement with the previous observation by Hood *et al.* ([@B15]) showing that VgrG1c overproduction resulted in the occurrence of a large number of high molecular weight bands in the supernatant. Furthermore, when the samples were not boiled to reduce disruption of protein complexes, the amount of VgrG complex detected was significantly increased ([Fig. 9](#F9){ref-type="fig"}*A*, *lanes 4* and *8*). The VgrG proteins are characterized by a C terminus containing octapeptide Val-Xaa-Gly-Xaa-Xaa-Xaa-Xaa-Xaa repeats similar to the C-terminal domain of the gp5 protein. It was previously reported that this gp5 domain forms a trimer with a β-helix structure (see [supplemental Fig. S2](http://www.jbc.org/cgi/content/full/M110.193045/DC1)) that is very stable and resistant to denaturation by SDS ([@B33], [@B34]). This is in agreement with the observed VgrG complex in our SDS-containing acrylamide gels ([Fig. 9](#F9){ref-type="fig"}). In order to further characterize the complex, we performed similar experiments using isogenic *vgrG1a* and *vgrG1c* mutants. The complex was still detectable in the *vgrG1a* mutant supernatant, although the monomeric form of VgrG1a was no longer detectable ([Fig. 9](#F9){ref-type="fig"}*A*, *lane 5*). In the *vgrG1c* mutant supernatant, the complex was also observed but in reduced quantities compared with the supernatant of the *retS* mutant ([Fig. 9](#F9){ref-type="fig"}*A*, *lane 6*). The complex was no longer detectable ([Fig. 9](#F9){ref-type="fig"}*A*, *lane 7*) in a double *vgrG1a/vgrG1c* mutant, suggesting that the complex contains both VgrG1a and VgrG1c. However, it is not possible to conclude whether VgrG1a and VgrG1c could form heteromultimeric complexes.

![**Multimeric complexes formed by VgrG proteins.** Cell extracts (*Cells*) and proteins from culture supernatants (*SN*) of PAKΔ*retS* and PAKΔ*retS* mutant derivatives *vgrG1a* (*G1a*), *vgrG1b* (*G1b*), *vgrG1c* (*G1c*), double *vgrG1a/vgrG1b* (*G1ab*), double *vgrG1a/vgrG1c* (*G1ac*), and double *vgrG1b/vgrG1c* (*G1bc*) (indicated *above* each *lane* where appropriate) were analyzed by immunoblotting. Samples were not boiled prior to analysis by SDS-PAGE and immunoblotting (*unboiled*) unless otherwise indicated (*boiled*). *A*, VgrG proteins were detected using antibodies directed against VgrG1a. *B*, VgrG proteins were detected using antibodies directed against VgrG1a or VgrG1b, as indicated. The positions of VgrG1a (*G1a*), VgrG1b (*G1b*), VgrG1c (*G1c*), and the VgrG complex are indicated on the *left*. The band marked with an *asterisk* is an uncharacterized protein recognized by antibodies directed against VgrG1b. Molecular mass standards (kDa) are indicated on the *right*.](zbc0201158450009){#F9}

Using VgrG1b antibodies, a complex of similar molecular weight was detected in the supernatant of the PAKΔ*retS* strain ([Fig. 9](#F9){ref-type="fig"}*B*), most efficiently in the unboiled sample *versus* the boiled sample ([Fig. 9](#F9){ref-type="fig"}*B*, *lane 4 versus lane 3*). We observed that this complex was still detectable in a *vgrG1b* mutant ([Fig. 9](#F9){ref-type="fig"}*B*, *lane 5*), suggesting that the antibodies could recognize either VgrG1a or VgrG1c although the monomeric form of these VgrGs remained undetectable. The complex fully disappeared in a double mutant *vgrG1b/vgrG1c* ([Fig. 9](#F9){ref-type="fig"}*B*, *lane 7*) but was still present in a double mutant *vgrG1a/vgrG1b* ([Fig. 9](#F9){ref-type="fig"}*B*, *lane 6*), which suggests that it essentially consists of VgrG1c. Finally, no complexes were detected in a double *vgrG1a/vgrG1c* mutant, which suggests that VgrG1b does not form complexes or that these complexes are very unstable ([Fig. 9](#F9){ref-type="fig"}*B*, *lane 8*). It should be noted that because the VgrG1b antiserum detects the VgrG1c complex but not its monomeric form, it may recognize conformational epitopes.

#### VgrG-dependent Secretion of Tse3

It was recently shown that the H1-T6SS from *P. aeruginosa* is involved in the secretion of three novel substrates, non-VgrG effectors, named Tse1 to -3 ([@B15]). One of these, Tse2, was described as a toxin component arresting growth of prokaryotic and eukaryotic cells. It was shown that secretion of VSV-G-tagged Tse proteins is ClpV1-dependent. Here, we generated polyclonal antibodies against Tse3 and assessed whether secretion of chromosomally encoded Tse3 was dependent on VgrG1a, VgrG1b, or VgrG1c. Our data confirmed that Tse3 is clearly detected in the *retS* background (increased expression of *H1-T6SS* genes) but not in the parental PAK strain ([Fig. 10](#F10){ref-type="fig"}). Furthermore, as we previously showed for Hcp1, none of the single mutations in *vgrG1a*, *vgrG1b*, or *vgrG1c* abolished Tse3 secretion ([Fig. 10](#F10){ref-type="fig"}). However, when all three *vgrG* genes were deleted (*vgrG1a/b/c*), Tse3 was no longer detected in the supernatant, whereas it was still found in the cellular fraction. This demonstrated that Tse3 secretion is VgrG-dependent, but there are no clear signs of specificity for one or another VgrG.

![**VgrG-dependent secretion of Tse3.** Cell extracts (*Cells*) and proteins from culture supernatants (*SN*) of PAK, PAKΔ*retS* (*retS*), and PAKΔ*retS* mutant derivatives *vgrG1A, vgrG1B, vgrG1C*, and triple *vgrG1a/vgrG1b/vgrG1c (vgrG1a/b/c*) (indicated *above* each *lane*) were separated by SDS-PAGE and analyzed by immunoblotting. Tse3 protein was detected using specific polyclonal antibodies directed against Tse3 peptides. RNAP was detected using an antibody directed against its β subunit. The positions of Tse3, RNAP, and molecular mass standards (kDa) are indicated on the *right*.](zbc0201158450010){#F10}

DISCUSSION
==========

The discovery of the T6SS shed new light on the strategy used by bacterial pathogens to successfully infect their host ([@B11], [@B14]). The T3SS and T4SS have been described as injecting bacterial effectors into host cells and consequently manipulating the host response for their own benefit ([@B9]). Because the T6SS was initially discovered as being specifically induced *in vivo* and because T6SS appeared to be activated upon host cell contact ([@B11], [@B20]), it was proposed that it could fulfill a similar function and that putative effector proteins should be associated with the T6SS.

Very little knowledge is available about the characterization of these effectors and about proteins secreted in a T6SS-dependent manner. It was determined that Hcp is a bacteriophage gp19 homologue and could form a tube as part of the T6SS machinery ([@B18], [@B35]). This tube could span the bacterial cell envelope and become cell surface-exposed, which would explain why Hcp is recovered from bacterial culture supernatants. VgrG proteins were also described as bacteriophage protein homologues. VgrGs are composite proteins, all containing a domain similar to gp5 and a domain similar to gp27. The association of gp5 and gp27 in the bacteriophage infection process results in the formation of a puncturing device, which sits on the tip of the gp19 tube and perforates the membrane, thus allowing phage DNA injection into the bacterial cell. Based on this model, VgrG proteins may sit at the tip of the Hcp tube and could be released into the extracellular medium. Only few proteins have been described to be secreted in a T6SS-dependent manner, such as RbsB from *Rhizobium leguminosarum* ([@B36]) or IglI from *Francisella tularensis* ([@B37]). It was shown recently that three proteins, Tse1 to -3, are substrates for the *P. aeruginosa* H1-T6SS ([@B15]). Among them, Tse2 is a toxin that is targeted to prokaryotic cells. Alternatively, effector domains have been identified at the C terminus of VgrG proteins, which are referred to as evolved VgrGs. The C-terminal domain may be an adhesin or an enzyme for example. Only two of these evolved VgrGs have been experimentally studied, VgrG1 from *V. cholerae* ([@B19], [@B31]) and from *A. hydrophila* ([@B20]). In both cases, it was shown that the activity associated with the VgrG C-terminal domain, ACD, or VIP-2, respectively, was involved in remodeling the actin cytoskeleton of the host cell.

Genome mining in *P. aeruginosa* identified three *T6SS* clusters (*H1*- to *H3-T6SS*). Furthermore, we showed here that 10 *vgrG* genes could be identified on the PAO1 chromosome. Previous work using mass spectrometry analysis showed that at least two *P. aeruginosa* VgrGs, VgrG1 (PA0091) and VgrG4 (PA2685), were not recovered in the supernatant of an *H1-T6SS* mutant (*clpV1* mutant) and therefore could be substrate for the H1-T6SS machinery ([@B15]). The authors confirmed this observation by overproducing VSV-tagged versions of the VgrG proteins and by following secretion using standard Western blot analysis. We focused our work on VgrG1, which we renamed here VgrG1a, and generated antibodies directed against this protein to follow its fate when expressed from the chromosomal gene. This protein is a standard VgrG protein without any C-terminal extension. Here, we confirmed that VgrG1a is efficiently secreted, and we demonstrated that at least two other VgrGs are also secreted, VgrG1b and VgrG1c. It is important to recall that VgrG1a is only detected in the *retS* mutant in which the *vgrG1a/PA0091* gene is up-regulated (30-fold) ([@B27]). The transcriptomic analysis revealed that *vgrG1b/PA0095* (3.7-fold) and *vgrG1c/PA2685* (4.3-fold) are also up-regulated in a *retS* mutant, which explains why they are detected in the same conditions. In contrast to *vgrG1b*, which is located within the vicinity of *vgrG1a* and the *H1-T6SS* gene cluster, *vgrG1c* is located at a different locus and not clustered with any *T6SS* genes ([Fig. 2](#F2){ref-type="fig"}*A*). Not only is the production of these three VgrG proteins coordinated, but they are closely related when compared with the seven other VgrG proteins ([Fig. 2](#F2){ref-type="fig"}*B*). VgrG1c/PA2685 corresponds to the previously described VgrG4 ([@B15]), but we propose to rename the VgrG proteins according to their proximity in the phylogenetic tree ([Fig. 2](#F2){ref-type="fig"}*B*). We also observed that neither VgrG1b nor VgrG1c contain a C-terminal extension ([Fig. 3](#F3){ref-type="fig"}). In summary, we showed that three *P. aeruginosa* VgrGs are secreted, but none of them could be considered as an effector protein.

Next we analyzed the T6SS-dependent secretion of these VgrG proteins. Although we confirmed that VgrG1a and VgrG1c secretion is drastically reduced in a *clpV1* mutant, VgrG1b secretion seems to remain unaffected. Furthermore, VgrG1b is still secreted in strains containing a mutation in any of the three T6SS clusters, suggesting that VgrG1b secretion can occur in a T6SS-independent manner. The reason for such behavior is unclear, but T6SS-independent secretion of VgrG proteins has also been reported in *F. tularensis* ([@B37]).

It has been proposed that VgrG proteins form trimeric complexes similar to the (gp27)~3~(gp5)~3~ tail spike structure of the T4 phage. We confirmed here using a three-dimensional structure model that this applies to VgrG1a ([supplemental Fig. S2](http://www.jbc.org/cgi/content/full/M110.193045/DC1)). When we analyzed the multimeric state of the VgrG proteins isolated from the supernatant of *P. aeruginosa* cultures, we observed that both VgrG1a and VgrG1c are capable of assembling into a multimeric form. This complex disappears only when both *vgrG1a* and *vgrG1c* genes are deleted. However, it is noticeable that when analyzing samples from a *vgrG1a* mutant, only the multimeric form of VgrG1c is detected. In contrast, analyzing samples from the *vgrG1c* mutant indicates that whereas VgrG1a complex is detectable, a large amount of monomeric VgrG1a is also detectable, suggesting that the complex is less stable. The presence of VgrG1b complex could not be shown using anti-VgrG1b antibodies, which might suggest that, if formed, the VgrG1b complex is very unstable.

Although three *P. aeruginosa* VgrGs appeared co-regulated and highly similar at the amino acid sequence level, none of them showed similar behavior in terms of secretion or multimerization. This discrepancy might suggest that each of the three VgrGs fulfills an independent function or allows a significant level of specificity. For example, if we consider VgrGs as a puncturing device, non-evolved VgrGs might serve the secretion of yet unknown proteins with which they may interact specifically. For example, we hypothesized that VgrG1a is involved in the secretion of one of the Tse proteins, whereas VgrG1c may be required for the secretion of a different Tse. In this way, each complex, VgrG1a or VgrG1c, together with their cognate exoproteins, might sit independently or alternatively on the tip of the Hcp1 tube. As for the evolved VgrG, it will have a dual function, which is on the one hand to perforate the membrane and on the other hand to carry an effector or secreted protein. If this is true, we might expect that accessibility of Hcp1 to the external milieu would depend either on VgrG1a or VgrG1c. This is exactly what we observed because Hcp1 secretion was reduced in a *vgrG1a* or a *vgrG1c* mutant but was abolished in a double *vgrG1a/vgrG1c* mutant.

In conclusion, we point out the remarkable feature that although release in the extracellular medium might be a general feature of VgrG proteins, there is a lot more subtlety in the function of these components. The large number of *vgrG* genes in *P. aeruginosa* is probably not the result of a duplication but rather a gain in specificity for the system, which might modulate its secretion profile according to the situation encountered within the host. Future work will aim at better understanding the exact role played by the non-evolved VgrGs, which we suspect is not exclusively to provide a channel through the cell envelope but also to specifically interact with yet unknown secreted proteins, such as the recently characterized Tse1 to -3 proteins ([@B15]). Our data regarding Tse secretion showed that although Tse3 secretion is VgrG-dependent, all three VgrGs need to be absent to prevent Tse3 release, thus showing no sign of specificity in this case. We still need to develop a refined quantitative assay to rule out any VgrG specificity, and we will further address VgrG-dependent secretion of Tse1 and Tse2. For the time being, two categories of VgrGs can be described. The evolved VgrGs form one block, including the puncturing device and the secreted domain covalently bound at the C terminus. This will conceptually resemble an autotransporter system ([@B38]). The standard VgrGs, such as VgrG1a, VgrG1b, and VgrG1c, described in this study, contain the sole puncturing device but could possibly recognize a secreted substrate. If this turns out to be the case, it will conceptually resemble a two-partner system.

The on-line version of this article (available at <http://www.jbc.org>) contains [supplemental Figs. S1 and S2](http://www.jbc.org/cgi/content/full/M110.193045/DC1).

The abbreviation used is: RNAPRNA polymerase.
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